tiprankstipranks
CERo Therapeutics Holdings (CERO)
NASDAQ:CERO
US Market

CERo Therapeutics Holdings (CERO) Stock Price & Analysis

65 Followers

CERO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.33 - $12.80
Previous Close$1.37
Volume94.32K
Average Volume (3M)1.09M
Market Cap
$20.17M
Enterprise Value$20.07M
Total Cash (Recent Filing)$96.87K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-3.6
Beta>-0.01
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding14,723,565
10 Day Avg. Volume106,412
30 Day Avg. Volume1,092,900
Standard Deviation0.14
R-Squared0.02
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.42
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-27.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-8.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

19.88%8.70%5.12%66.30%
19.88% Insiders
5.12% Other Institutional Investors
66.30% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

CERO FAQ

What was CERo Therapeutics Holdings’s price range in the past 12 months?
CERo Therapeutics Holdings lowest stock price was $1.33 and its highest was $12.80 in the past 12 months.
    What is CERo Therapeutics Holdings’s market cap?
    Currently, no data Available
    When is CERo Therapeutics Holdings’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were CERo Therapeutics Holdings’s earnings last quarter?
    Currently, no data Available
    Is CERo Therapeutics Holdings overvalued?
    According to Wall Street analysts CERo Therapeutics Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does CERo Therapeutics Holdings pay dividends?
      CERo Therapeutics Holdings does not currently pay dividends.
      What is CERo Therapeutics Holdings’s EPS estimate?
      CERo Therapeutics Holdings’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does CERo Therapeutics Holdings have?
      CERo Therapeutics Holdings has 14,723,565 shares outstanding.
        What happened to CERo Therapeutics Holdings’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of CERo Therapeutics Holdings?
        Among the largest hedge funds holding CERo Therapeutics Holdings’s share is Saba Capital Management. It holds CERo Therapeutics Holdings’s shares valued at N/A.
          ---

          CERo Therapeutics Holdings Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Technicals

          SMA
          Negative
          20 days / 200 days
          Momentum
          -87.52%
          12-Months-Change

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -79.79%
          Trailing 12-Months

          Company Description

          CERo Therapeutics Holdings

          Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Private Bancorp of America
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis